Product Description
lower price 99-101% White crystalline powder Scopolamine hydrobromide 114-49-8
AI Product Description
*The following content is generated by AI and is for reference only.
Scopolamine hydrobromide, a white crystalline powder with a purity range of 99% to 101%, is a widely utilized pharmaceutical compound derived from the tropane alkaloid family. Its molecular formula is C₁₇H₂₁BrN₂O₄, and it is identified by the CAS Registry Number 6533-67-7. This substance serves as a potent anticholinergic agent, primarily functioning by blocking muscarinic acetylcholine receptors in the central and peripheral nervous systems. The "lower price" designation often associated with this product in current market listings suggests competitive sourcing for bulk procurement, making it an economical choice for pharmaceutical manufacturers and research institutions alike.
The primary clinical application of Scopolamine hydrobromide is the prevention and treatment of motion sickness, including nausea and vomiting induced by travel. It is frequently administered via transdermal patches, oral tablets, or injectable solutions depending on the specific medical requirement. Beyond its antiemetic properties, the compound is also employed in pre-anesthetic medication to reduce salivary and bronchial secretions, thereby facilitating smoother surgical procedures. In ophthalmology, it acts as a mydriatic and cycloplegic agent to dilate the pupil and paralyze accommodation during eye examinations. Furthermore, due to its ability to cross the blood-brain barrier, it is sometimes investigated for its sedative effects in managing severe agitation or delirium.
Despite its therapeutic benefits, Scopolamine hydrobromide requires careful handling due to potential side effects such as dry mouth, blurred vision, drowsiness, and confusion, particularly in elderly patients. Strict adherence to dosage guidelines is essential to avoid toxicity. The high purity standard of 99–101% ensures consistent efficacy and safety profiles in both industrial synthesis and clinical formulations. As a versatile molecule, it remains a cornerstone in modern pharmacotherapy for motion disorders and perioperative care. Researchers continue to explore novel delivery systems to enhance bioavailability while minimizing systemic adverse reactions. For global supply chains, securing cost-effective sources of this high-grade chemical is vital for maintaining affordable healthcare solutions worldwide.